Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest.
Rodencal J, Kim N, He A, Li VL, Lange M, He J, Tarangelo A, Schafer ZT, Olzmann JA, Long JZ, Sage J, Dixon SJ. Rodencal J, et al. Among authors: kim n. Cell Chem Biol. 2024 Feb 15;31(2):234-248.e13. doi: 10.1016/j.chembiol.2023.10.011. Epub 2023 Nov 13. Cell Chem Biol. 2024. PMID: 37963466
A Cell Cycle-Dependent Ferroptosis Sensitivity Switch Governed by EMP2.
Rodencal J, Kim N, Li VL, He A, Lange M, He J, Tarangelo A, Schafer ZT, Olzmann JA, Sage J, Long JZ, Dixon SJ. Rodencal J, et al. Among authors: kim n. bioRxiv [Preprint]. 2023 Jul 19:2023.07.19.549715. doi: 10.1101/2023.07.19.549715. bioRxiv. 2023. PMID: 37502927 Free PMC article. Preprint.
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis.
Calhoon D, Sang L, Bezwada D, Kim N, Basu A, Hsu SC, Pimentel A, Brooks B, La K, Serrano AP, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Margulis V, Cai F, Brugarolas J, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J. Calhoon D, et al. Among authors: kim n. bioRxiv [Preprint]. 2024 May 13:2024.05.13.593939. doi: 10.1101/2024.05.13.593939. bioRxiv. 2024. PMID: 38765991 Free PMC article. Preprint.
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
Salani R, McCormack M, Kim YM, Ghamande S, Hall SL, Lorusso D, Barraclough L, Gilbert L, Guzman Ramirez A, Lu CH, Sabatier R, Colombo N, Hu Y, Krishnan V, Molinero L, Feng Y, Kim N, Castro M, Lin YG, Monk BJ. Salani R, et al. Among authors: kim n. Int J Gynecol Cancer. 2024 Jun 10:ijgc-2024-005588. doi: 10.1136/ijgc-2024-005588. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38858106
A roadmap to human hippocampal neurogenesis in adulthood, aging and AD.
Lazarov O, Disouky A, Sanborn M, Mostafa M, Sabitha K, Schantz A, Kim N, Pawlowski S, Honer W, Bennett D, Zhou Y, Keene C, Maienschein-Cline M, Rehman J. Lazarov O, et al. Among authors: kim n. Res Sq [Preprint]. 2024 May 30:rs.3.rs-4469965. doi: 10.21203/rs.3.rs-4469965/v1. Res Sq. 2024. PMID: 38854131 Free PMC article. Preprint.
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial.
Kim NH, Moon JS, Lee YH, Cho HC, Kwak SH, Lim S, Moon MK, Kim DL, Kim TH, Ko E, Lee J, Kim SG. Kim NH, et al. Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15705. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38853720
11,643 results
You have reached the last available page of results. Please see the User Guide for more information.